Inhibitors of Post-Translational Modifications of G-Proteins as Probes to Study the Pancreatic β Cell Function: Potential Therapeutic Implications
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
2
Page:
129-139
Author(s):
A. Kowluru and R. Amin
Cross-talk between Cellular Stress, Cell Cycle and Anticancer Agents: Mechanistic Aspects
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
553-566
Author(s):
E. Tiligada, V. Miligkos and A. Delitheos
Preface
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
i-i
Author(s):
Peter M. Brooks
COX Selectivity and Animal Models for Colon Cancer
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1021-1034
Author(s):
Masanobu Oshima and Makoto M. Taketo
The Role of Cyclooxygenase Inhibitors in Cancer Prevention
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1035-1062
Author(s):
William F. Anderson, Asad Umar, Jaye L. Viner and Ernest T. Hawk
Comparative Analgesia, Cardiovascular and Renal Effects of Celecoxib, Rofecoxib and Acetaminophen (Paracetamol)
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1063-1075
Author(s):
Garry G. Graham, Robert I. Graham and Richard O. Day
Gastrointestinal Safety of Selective COX-2 Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1077-1089
Author(s):
C. J. Hawkey and M. M. Skelly
Furosemide Protective Effect Against Airway Obstruction
Journal:
Current Drug Targets
Volume:
3
Page:
197-201
Author(s):
Franco Cavaliere and Simonetta Masieri
Multiple Drug Targets in the Management of Type 2 Diabetes
Journal:
Current Drug Targets
Volume:
3
Page:
203-221
Author(s):
M.H. Moneva and S. Dagogo-Jack
Novel Molecular Targets for Systemic Lupus Erythematosus
Journal:
Current Drug Targets
Volume:
3
Page:
223-228
Author(s):
Maria Marino, Maria Rossi, Menotti Ruvo and Giorgio Fassina